RKDAArcadia Biosciences, Inc. · NASDAQ Capital Market · $389.3K mkt cap
Assessed Aug 28, 2026 · Reassessment
Is the float you're seeing correct?
2.41M
Actual float

Outstanding (10-Q cover 2026-08-06) less actual common shares held by officers and directors.

Understated 19%
2.03M
Reported float

Data-service feed, fetched today. The number TradingView and most screeners show.

Your screener is showing a float that no longer exists. Trade off 2.41M shares.

Dilution risk8/10HIGH
CONFIDENCE: HIGH

The float your screener shows is understated 19%: 2.03M reported, 2.41M actual. 2 reverse splits can add another 569% of the float.

  • Near-zero-strike pre-funded warrant overhang. 3,656,000 unexercised pre-funded warrants at a $0.0001 exercise price sit outside the reported float, equal to 152% of the entire 2.41M-share float.

  • Total derivative overhang vs. float. 13,684,226 shares underlie outstanding warrants, preferred investment options and employee options against a float of 2,405,678 — 569% of float, or 5.7x.

  • Rapid realized share count growth. Deterministic XBRL share counts show outstanding rising from 1,367,040 (2025-08-07) to 2,409,211 (2026-08-06) — a 76.2% increase in twelve months — with 17.1% (+352,327 shares) of that occurring in j…

From today's float to the ceiling

shares
2.41M
Actual float
tradeable today
+3.66M can sell now
6.06M
Effective supply
float plus what sells on notice
+10.03M if floors are cut and warrants exercise
16.09M
Fully diluted
ceiling

Where the shares come from

each subtotal is a rung on the ladder above

Tradeable today
2.41M
Can sell now
Warrants in the money, at or near a zero strike
Exercisable at or below the current tape.
+3.66M
Effective supply
6.06M
Above the current price
Warrants out of the money
Struck above the current tape; supply only if the stock rises.
+9.85M
Options and RSUs
Employee equity; vests and settles over time.
+173.9K
Other, per engine ceiling
Included in the engine's fully-diluted count but not itemised in the filings we parsed.
+3.5K
Fully diluted
16.09M

Not counted anywhere: ATM and shelf capacity. Convertible share counts use stated conversion prices.

See the full breakdown

Red flags, financing counterparties, the deal timeline, and every SEC filing — free with an account.

Sign in to continue

The facts

Price
—
Market cap
$389.3K
Shares outstanding
2.41M
Reported float
2.03M
Avg volume
5.99M
Reverse splits
2 · latest 1-for-40 · Mar 1, 2023
Going concern
Yes · 2.3 quarters runway
Quarterly burn
$1.80M

Market data as of Oct 25, 2026

Key dates

  • Feb 1, 2027 · Nasdaq bid-price compliance deadline — forcing function for the reverse split
  • Jun 12, 2027 · Expiration of the one-year Variable Rate Transaction prohibition, after which floating-price/toxic structures become contractually available again
  • Jul 8, 2028 · Series A-2 preferred investment options expire (3,883,496 shares at $0.91)
  • Aug 10, 2028 · January 2026 investment options expire (1,617,190 shares at $2.325)